Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06530498
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-28
Brief Title:
Diagnostics of Clinical Hyperandrogenism
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Diagnostics of Clinical Hyperandrogenism Using the Modified Ferriman-Gallwey Scale and the Ludwig Scale in Women With Normogonadotropic Anovulation
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The optimal cut-off value for diagnosing hirsutism in the modified Ferriman-Gallwey mFG point scale in the Polish population is not known The correlation of mFG with the severity of androgenetic alopecia in the Ludwig scale LS is not known
The aim of the study is to determine the cut-off point for the diagnosis of hirsutism and to assess the correlation of the mFG scale score with the LS of androgenetic alopecia severity
The aim of the study is to determine the cut-off point for the diagnosis of hirsutism and to assess the correlation of the mFG scale score with the LS of androgenetic alopecia severity
Detailed Description:
The aim of the study is to
determine the cut-off point on the mFG scale indicating hirsutism and to determine the correlation of the severity of androgenetic alopecia on the Ludwig scale with the mFG value in the population of women diagnosed and treated at the University Hospital in Krakow due to anovulation
to determine the severity of hirsutism and the severity of androgenetic alopecia in individual PCOS phenotypes
Inclusion criteria are as follows i oligoovulation ie menstrual cycles every 21 days or 35 days ii age 18-45 years iii diagnosis of PCOS
Exclusion criteria none
To achieve the study objectives the following will be performed
Visual assessment of the severity of hirsutism on the modified Ferriman-Gallwey scale
Visual assessment of the severity of androgenetic alopecia on the Ludwig scale
determine the cut-off point on the mFG scale indicating hirsutism and to determine the correlation of the severity of androgenetic alopecia on the Ludwig scale with the mFG value in the population of women diagnosed and treated at the University Hospital in Krakow due to anovulation
to determine the severity of hirsutism and the severity of androgenetic alopecia in individual PCOS phenotypes
Inclusion criteria are as follows i oligoovulation ie menstrual cycles every 21 days or 35 days ii age 18-45 years iii diagnosis of PCOS
Exclusion criteria none
To achieve the study objectives the following will be performed
Visual assessment of the severity of hirsutism on the modified Ferriman-Gallwey scale
Visual assessment of the severity of androgenetic alopecia on the Ludwig scale
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None